Product Information

LEVOTHYROXINE 300 MCG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0999 per EA under NDC 00378182177. Its NADAC has been published 524 times since Aug 10, 2016.

FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3,AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOTHYROXINE 300 MCG TABLET

levothyroxine sodium
$0.0999per EA

Strength

300 ug/1

NDC

00378182177

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA076187

FDA Approved

6/5/2002

TE Code

AB1,AB2,AB3,AB4

On Market Since

11/1/2002

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOTHYROXINE 300 MCG TABLET has been published 524 times since Aug 10, 2016, and over the history we have for it it has declined 87.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0999 per EA
All-time high$0.8465 (Oct 12, 2016)
All-time low$0.0715 (Jul 17, 2024)
52-week high$0.1278
52-week low$0.0999
Median price$0.4669
Average price$0.4209
Largest weekly change+78.9% (Aug 21, 2024)
Weeks tracked524
Tracking sinceAug 10, 2016

Price History

1W

-6.4%

1M

-7.9%

3M

-11.3%

6M

-13.6%

1Y

-21.9%

3Y

-37.3%

5Y

-79.5%

All

-87.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of LEVOTHYROXINE 300 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 300 MCG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0999 per EA (NDC 00378182177), effective Aug 19, 2026.

How has the price of LEVOTHYROXINE 300 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOTHYROXINE 300 MCG TABLET has declined 87.1%. It has been tracked across 524 weekly CMS publications since Aug 10, 2016.

What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 300 MCG TABLET?

Since Aug 10, 2016, the NADAC for LEVOTHYROXINE 300 MCG TABLET has ranged from a low of $0.0715 (Jul 17, 2024) to a high of $0.8465 (Oct 12, 2016), with a median of $0.4669 per EA.

Are there cheaper alternatives to LEVOTHYROXINE 300 MCG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 300 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LEVOTHYROXINE 300 MCG TABLET?

LEVOTHYROXINE 300 MCG TABLET (NDC 00378182177) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.